Search research articles
Contact Us
Filters
Showing results (31-40 of 52) with videos related to
Page
of 6
Sort By:
Annals of the Rheumatic Diseases
|
July 1, 1991
Hepatic methotrexate content and progression of hepatic fibrosis: preliminary findings
M J Ahern, S Kevat, W Hill, et al.
Alcoholism, Clinical and Experimental Research
|
December 1, 1994
Alcohol/"low-dose" carbon tetrachloride-induced cirrhosis in rats using different methods of alcohol feeding
J L Plummer, P D Hall, P L Cmielewski, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
April 1, 1996
Inquiring about sexual abuse
C S Al-Mateen, R Brookman, A M Best, et al.
Hepatology (Baltimore, Md.)
|
November 1, 1991
Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridization
R A McKinnon, P D Hall, L C Quattrochi, et al.
Hepatology (Baltimore, Md.)
|
May 1, 1991
Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen
S M Cole, E J Gowans, T B Macnaughton, et al.
Acta Pharmacologica Et Toxicologica
|
July 1, 1983
Hepatic injury in rats due to prolonged sub-anaesthetic halothane exposure
J L Plummer, P D Hall, M J Cousins, et al.
Acta Pharmacologica Et Toxicologica
|
September 1, 1985
Hepatic and renal effects of prolonged exposure of rats to 50 p.p.m. methoxyflurane
J L Plummer, P D Hall, M A Jenner, et al.
Digestive Diseases (Basel, Switzerland)
|
November 4, 2000
Electrolytic treatment of colorectal liver tumour deposits in a rat model: a technique with potential for patients with unresectable liver tumours
S A Wemyss-Holden, G S Robertson, P D Hall, et al.
Annals of the Rheumatic Diseases
|
July 1, 1991
Two methods of assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis
P D Hall, M J Ahern, L R Jarvis, et al.
Clinical Immunology (Orlando, Fla.)
|
July 24, 2001
Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia
P D Hall, G Virella, T Willoughby, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 52) with videos related to
Sort By:
Page
of 6
Annals of the Rheumatic Diseases
|
July 1, 1991
Hepatic methotrexate content and progression of hepatic fibrosis: preliminary findings
M J Ahern, S Kevat, W Hill, et al.
Alcoholism, Clinical and Experimental Research
|
December 1, 1994
Alcohol/"low-dose" carbon tetrachloride-induced cirrhosis in rats using different methods of alcohol feeding
J L Plummer, P D Hall, P L Cmielewski, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
April 1, 1996
Inquiring about sexual abuse
C S Al-Mateen, R Brookman, A M Best, et al.
Hepatology (Baltimore, Md.)
|
November 1, 1991
Localization of CYP1A1 and CYP1A2 messenger RNA in normal human liver and in hepatocellular carcinoma by in situ hybridization
R A McKinnon, P D Hall, L C Quattrochi, et al.
Hepatology (Baltimore, Md.)
|
May 1, 1991
Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen
S M Cole, E J Gowans, T B Macnaughton, et al.
Acta Pharmacologica Et Toxicologica
|
July 1, 1983
Hepatic injury in rats due to prolonged sub-anaesthetic halothane exposure
J L Plummer, P D Hall, M J Cousins, et al.
Acta Pharmacologica Et Toxicologica
|
September 1, 1985
Hepatic and renal effects of prolonged exposure of rats to 50 p.p.m. methoxyflurane
J L Plummer, P D Hall, M A Jenner, et al.
Digestive Diseases (Basel, Switzerland)
|
November 4, 2000
Electrolytic treatment of colorectal liver tumour deposits in a rat model: a technique with potential for patients with unresectable liver tumours
S A Wemyss-Holden, G S Robertson, P D Hall, et al.
Annals of the Rheumatic Diseases
|
July 1, 1991
Two methods of assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis
P D Hall, M J Ahern, L R Jarvis, et al.
Clinical Immunology (Orlando, Fla.)
|
July 24, 2001
Antibody response to DT-GM, a novel fusion toxin consisting of a truncated diphtheria toxin (DT) linked to human granulocyte-macrophage colony stimulating factor (GM), during a phase I trial of patients with relapsed or refractory acute myeloid leukemia
P D Hall, G Virella, T Willoughby, et al.
Page
of 6